Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by CURE Pharmaceutical Holding Corp.

CURE Pharmaceutical Receives Patent Approval for Its CUREfilm Blue™ Technology
From CURE Pharmaceutical Holding Corp.
Via Business Wire
Tickers OTC
CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines
From CURE Pharmaceutical Holding Corp.
Via Business Wire
Tickers CURR
CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference
From CURE Pharmaceutical Holding Corp.
Via Business Wire
Tickers CURR
CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health
From CURE Pharmaceutical Holding Corp.
Via Business Wire
Tickers CURR
CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021
From CURE Pharmaceutical Holding Corp.
Via Business Wire
Tickers CURR
CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics
From CURE Pharmaceutical Holding Corp.
Via Business Wire
Tickers CURR
CURE Pharmaceutical Receives ISO Certification for Laboratory and Manufacturing Facility
From CURE Pharmaceutical Holding Corp.
Via Business Wire
Tickers CURR
CURE Pharmaceutical Announces Successful Results From Initial Clinical Trials for Erectile Dysfunction Product CUREfilm Blue™
From CURE Pharmaceutical Holding Corp.
Via Business Wire
Tickers CURR
CURE Pharmaceutical to Present at the 2021 Sequire Cannabis Conference on Tuesday, April 20, at 2 p.m. EDT/11 a.m. PDT
From CURE Pharmaceutical Holding Corp.
Via Business Wire
Tickers OTC
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.